Home ›
NPI 1942241351
NPI deactivated
1942241351
1942241351 was paid $12.22M by Medicaid between Jan 2018 and Jul 2024, across 228 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 29% of everything it billed.
33Billing provider info1942241351
33aNPI1942241351
33bProvider type—
28Total paid$12.22M
24GClaims364,901
24DCodes billed228
24AFirst – last monthJan 2018 – Jul 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 89,775 | $2.39M | |
| 2019 | 59,040 | $2.27M | |
| 2020 | 52,253 | $2.04M | |
| 2021 | 65,686 | $2.84M | |
| 2022 | 55,312 | $1.81M | |
| 2023 | 38,252 | $731K | |
| 2024incomplete | 4,583 | $137K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 29% | 67,212 | 56,542 | $3.52M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 25,535 | 21,945 | $1.94M |
| 90837 | Psychotherapy session, about an hourPsychotherapy, 53 minutes with patient | 3.3% | 4,765 | 3,173 | $398K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.8% | 2,322 | 2,232 | $342K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.8% | 6,526 | 6,336 | $341K |
| 80053 | Comprehensive metabolic panel | 2.5% | 15,104 | 13,808 | $306K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 2.4% | 9,985 | 5,210 | $296K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 1.5% | 5,771 | 5,459 | $186K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | 1.4% | 2,681 | 1,733 | $170K |
| 76830 | Ultrasound, transvaginal | 1.3% | 1,140 | 1,082 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.3% | 4,312 | 4,120 | $153K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 6,523 | 6,338 | $152K |
216 more codes
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 1.2% | 3,613 | $145K |
| 80061 | Lipid panel | 1.1% | 7,933 | $140K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.0% | 17,463 | $126K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.0% | 1,620 | $125K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 1,269 | $122K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 5,493 | $118K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,820 | $116K |
| 73562 | <1% | 3,165 | $113K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 5,546 | $106K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,591 | $104K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 1,609 | $103K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,773 | $103K |
| 73630 | <1% | 3,596 | $98K | |
| 80050 | General health panel | <1% | 892 | $97K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 1,313 | $95K |
| 36415 | Collection of venous blood by venipuncture | <1% | 33,549 | $87K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 1,196 | $79K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 3,403 | $77K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,184 | $76K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 1,969 | $75K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,261 | $72K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,888 | $72K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,285 | $72K |
| 73610 | <1% | 2,298 | $70K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,661 | $61K |
| 73110 | <1% | 1,740 | $59K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 1,164 | $56K |
| 73130 | <1% | 1,684 | $54K | |
| 90791 | Psychiatric diagnostic evaluation | <1% | 527 | $53K |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 642 | $52K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 683 | $52K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 1,332 | $49K |
| 76801 | <1% | 468 | $46K | |
| 73030 | <1% | 1,687 | $45K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 867 | $43K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 343 | $43K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 630 | $42K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,617 | $42K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,278 | $37K |
| 92015 | Determination of refractive state | <1% | 3,261 | $37K |
| 82728 | <1% | 1,798 | $36K | |
| 86803 | <1% | 1,921 | $34K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,315 | $34K |
| 82607 | <1% | 1,488 | $33K | |
| 83013 | <1% | 142 | $32K | |
| 73502 | <1% | 771 | $32K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 956 | $31K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 853 | $29K |
| 73140 | <1% | 862 | $28K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,306 | $22K |
| 90686 | <1% | 3,709 | $22K | |
| 76536 | <1% | 200 | $22K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 272 | $21K |
| 86780 | <1% | 1,398 | $21K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 214 | $21K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 218 | $20K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 260 | $18K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,673 | $18K |
| X5622 | <1% | 1,077 | $17K | |
| 97161 | <1% | 381 | $17K | |
| 83550 | <1% | 1,738 | $16K | |
| 0002A | <1% | 486 | $16K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 265 | $15K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,561 | $15K |
| 86140 | <1% | 2,408 | $15K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 175 | $13K |
| 87340 | <1% | 1,228 | $13K | |
| 0240U | <1% | 85 | $13K | |
| 0001A | <1% | 501 | $13K | |
| 76770 | <1% | 178 | $13K | |
| 84702 | <1% | 507 | $12K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 72 | $12K |
| 83540 | <1% | 1,773 | $12K | |
| 17110 | <1% | 160 | $11K | |
| 82043 | <1% | 1,262 | $11K | |
| 74018 | <1% | 525 | $11K | |
| 73080 | <1% | 446 | $11K | |
| 80076 | <1% | 354 | $11K | |
| 74019 | <1% | 429 | $10K | |
| S0302 | Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) | <1% | 1,114 | $10K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 190 | $10K |
| 90715 | <1% | 786 | $10K | |
| 88342 | <1% | 445 | $10K | |
| 87077 | <1% | 525 | $9K | |
| 81001 | <1% | 2,836 | $9K | |
| 90651 | <1% | 514 | $9K | |
| 82570 | <1% | 1,658 | $9K | |
| 83970 | <1% | 147 | $8K | |
| 90662 | <1% | 180 | $7K | |
| V2020 | Frames, purchases | <1% | 255 | $7K |
| 87186 | <1% | 519 | $7K | |
| 90670 | <1% | 1,104 | $6K | |
| 84439 | <1% | 786 | $6K | |
| 81025 | <1% | 947 | $6K | |
| 86480 | <1% | 53 | $6K | |
| 82746 | <1% | 289 | $6K | |
| 84403 | <1% | 157 | $6K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 123 | $6K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 385 | $6K |
| 85027 | <1% | 1,043 | $6K | |
| 86038 | <1% | 299 | $6K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 38 | $6K |
| 88307 | <1% | 292 | $5K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 122 | $5K |
| 84153 | <1% | 222 | $5K | |
| 80069 | <1% | 191 | $5K | |
| 87210 | <1% | 883 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 58 | $5K |
| 85610 | <1% | 636 | $4K | |
| 72100 | <1% | 135 | $4K | |
| 72170 | <1% | 231 | $4K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 116 | $4K |
| 83735 | <1% | 565 | $4K | |
| 73590 | <1% | 188 | $4K | |
| 87070 | <1% | 258 | $4K | |
| 86706 | <1% | 288 | $4K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 85 | $4K |
| 82784 | <1% | 142 | $4K | |
| V2784 | Lens, polycarbonate or equal, any index, per lens | <1% | 83 | $4K |
| 83690 | <1% | 370 | $3K | |
| 0054A | <1% | 83 | $3K | |
| 99307 | <1% | 144 | $3K | |
| 92567 | <1% | 321 | $3K | |
| V2103 | Spherocylinder, single vision, plano to plus or minus 4.00d sphere, .12 to 2.00d cylinder, per lens | <1% | 65 | $3K |
| 97035 | <1% | 358 | $3K | |
| 92341 | <1% | 90 | $3K | |
| 86850 | <1% | 125 | $3K | |
| 88341 | <1% | 50 | $3K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 53 | $3K |
| 84165 | <1% | 212 | $2K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 136 | $2K |
| 72110 | <1% | 49 | $2K | |
| 81003 | <1% | 1,168 | $2K | |
| 83615 | <1% | 326 | $2K | |
| 0071A | <1% | 56 | $2K | |
| 86762 | <1% | 180 | $2K | |
| 82274 | <1% | 44 | $2K | |
| 99188 | <1% | 452 | $2K | |
| 86592 | <1% | 358 | $2K | |
| 84481 | <1% | 93 | $2K | |
| 81015 | <1% | 416 | $2K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 276 | $2K |
| 86431 | <1% | 166 | $2K | |
| 99443 | <1% | 28 | $2K | |
| 93971 | <1% | 14 | $2K | |
| 88304 | <1% | 436 | $2K | |
| 0004A | <1% | 43 | $1K | |
| 85652 | <1% | 453 | $1K | |
| 82565 | <1% | 222 | $1K | |
| 99384 | <1% | 14 | $1K | |
| 92551 | <1% | 499 | $1K | |
| 73090 | <1% | 73 | $1K | |
| 73560 | <1% | 56 | $1K | |
| 90785 | <1% | 129 | $1K | |
| 84460 | <1% | 177 | $1K | |
| 0072A | <1% | 28 | $1K | |
| 84156 | <1% | 251 | $1K | |
| 86704 | <1% | 71 | $1K | |
| 83001 | <1% | 52 | $1K | |
| 87150 | <1% | 27 | $1K | |
| 84550 | <1% | 181 | $1K | |
| G0008 | Administration of influenza virus vaccine | <1% | 315 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 114 | $935.94 |
| 82670 | <1% | 29 | $926.93 | |
| 88108 | <1% | 42 | $840.79 | |
| 36416 | <1% | 340 | $818.41 | |
| 72082 | <1% | 14 | $764.53 | |
| 99442 | <1% | 26 | $657.32 | |
| 84146 | <1% | 30 | $594.68 | |
| 92557 | <1% | 24 | $579.25 | |
| 83880 | <1% | 12 | $553.35 | |
| 90734 | <1% | 318 | $527.57 | |
| 87205 | <1% | 93 | $501.46 | |
| 82550 | <1% | 42 | $499.72 | |
| 90474 | <1% | 40 | $495.21 | |
| 98968 | <1% | 24 | $452.85 | |
| 72040 | <1% | 15 | $429.47 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 100 | $407.17 |
| 0031A | <1% | 26 | $404.55 | |
| G0141 | Screening cytopathology smears, cervical or vaginal, performed by automated system, with manual rescreening, requiring interpretation by physician | <1% | 176 | $391.78 |
| 77072 | <1% | 25 | $381.84 | |
| Q3014 | Telehealth originating site facility fee | <1% | 227 | $348.10 |
| 71045 | Radiologic examination, chest; single view | <1% | 13 | $279.66 |
| 84484 | <1% | 14 | $274.67 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 42 | $270.71 |
| 84450 | <1% | 39 | $255.42 | |
| 88300 | <1% | 102 | $230.98 | |
| 99173 | <1% | 494 | $228.90 | |
| 99441 | <1% | 28 | $208.14 | |
| 88141 | <1% | 13 | $182.79 | |
| 88302 | <1% | 17 | $127.54 | |
| 85651 | <1% | 47 | $121.73 | |
| 86900 | <1% | 122 | $114.59 | |
| 86901 | <1% | 109 | $104.54 | |
| 85018 | <1% | 27 | $71.50 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 12 | $71.38 |
| 82950 | <1% | 12 | $66.26 | |
| 81002 | <1% | 13 | $47.26 | |
| 90461 | <1% | 16 | $38.21 | |
| 85379 | <1% | 13 | $35.11 | |
| 91307 | 0% | 100 | $0.00 | |
| 90698 | 0% | 887 | $0.00 | |
| 90680 | 0% | 249 | $0.00 | |
| 90744 | 0% | 183 | $0.00 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 13 | $0.00 |
| 97014 | 0% | 136 | $0.00 | |
| 90696 | 0% | 46 | $0.00 | |
| 91305 | 0% | 152 | $0.00 | |
| 92310 | 0% | 21 | $0.00 | |
| 88311 | 0% | 19 | $0.00 | |
| 91303 | 0% | 25 | $0.00 | |
| 91300 | 0% | 1,193 | $0.00 | |
| 90633 | 0% | 798 | $0.00 | |
| 90710 | 0% | 380 | $0.00 | |
| 90685 | 0% | 131 | $0.00 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.